Future Consumer Limited (BSE:533400) agreed to acquire Athena Life Sciences Private Limited for approximately INR 440 million on April 7, 2019. As per terms, consideration shall be paid by issue of equity shares on a proportionate basis, in the ratio determined, to each Shareholder /Member of Athena, whose name is registered in the Register of Members as on the Appointed Date provided under the Scheme. Under the terms, Future Consumer Limited will allot 13 fully paid up equity shares for every 83 fully paid up equity shares held by the shareholders of Athena as on the Appointed Date of April 1,2019, being the Record Date for the purpose of allotment of shares. The transaction is subjected to the approval of NCLT and other regulatory bodies as may be applicable. The Board of Directors of the Future Consumer and Athena had extended the timeline for approval of the Scheme up to September 30, 2021. As on July 16, 2021, the petition relating to the Scheme was listed for final hearing before the Hon'ble National Company Law Tribunal, Mumbai Bench. As of September 7, 2021, Future Consumer Limited has received the certified copy of the order issued by the Hon'ble National Company Law Tribunal, Mumbai Bench, sanctioning the transaction. The transaction is expected to complete on March 31, 2020.